NASDAQ:TSHA

Taysha Gene Therapies Stock Forecast

etoro logo Buy TSHA
*Your capital is at risk
$5.54
+0.0200 (+0.362%)
At Close: Jul 27, 2026
AI Analysis AI Analysis of TSHA AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TSHA to Watchlist?
Some Reasons Why To Add TSHA:
  • +107.5% price growth over the last year
  • High gross margin of 88.2%
  • Low bankruptcy risk (Altman Z-Score: 5.59)
PDF

Taysha Gene Therapies, Inc. stock price up 0.362% on Monday
(Updated on Jul 27, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 16, 2026 Loss -7.20%

The Taysha Gene Therapies, Inc. stock price gained 0.362% on the last trading day (Monday, 27th Jul 2026), rising from $5.52 to $5.54. During the last trading day the stock fluctuated 7.94% from a day low at $5.54 to a day high of $5.98. The price has been going up and down for this period, and there has been a 2.97% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 509 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $12.85 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.59% during the next 3 months and, with a 90% probability hold a price between $4.71 and $6.51 at the end of this 3-month period.

TSHA Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 13, 2026, and so far it has risen 2.97%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Taysha Gene Therapies, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.68 and $6.07. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Taysha Gene Therapies, Inc. stock

Taysha Gene Therapies, Inc. finds support from accumulated volume at $5.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.440 between high and low, or 7.94%. For the last week, the stock has had daily average volatility of 6.12%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TSHA) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Taysha Gene Therapies, Inc. to open at $5.69, and during the day (based on 14 day Average True Range), to move between $5.32 and $5.76, which gives a possible trading interval of +/-$0.432 (+/-8.12%) up or down from last closing price. If Taysha Gene Therapies, Inc. takes out the full calculated possible swing range there will be an estimated 8.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.49 (0.90%) than the resistance at $6.21 (12.09%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Taysha Gene Therapies, Inc. stock A Buy?

Taysha Gene Therapies, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.967 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $5.69 ( 2.65%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TSHA Performance

Trading levels for TSHA

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.13 10.59%
R2 5.96 7.56%
R1 5.85 5.68%
Price 5.54
S1 5.52 -0.387%
S2 5.41 -2.26%
S3 5.25 -5.29%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.81 22.92%
R2 6.34 14.44%
R1 6.21 12.09%
Price 5.54
S1 5.49 -0.90%
S2 5.38 -2.89%
S3 5.36 -3.25%

FAQ

What is the symbol for Taysha Gene Therapies, Inc. Stock and on which exchange is it traded?
The symbol for Taysha Gene Therapies, Inc. is TSHA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Taysha Gene Therapies, Inc. Stock?
Taysha Gene Therapies, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Taysha Gene Therapies, Inc. Stock?
Taysha Gene Therapies, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Taysha Gene Therapies, Inc. Stock.

What's the current price of Taysha Gene Therapies, Inc. Stock?
As of the end of day on the Jul 27, 2026, the price of an Taysha Gene Therapies, Inc. (TSHA) share was $5.54.

What is the 52-week high and low for Taysha Gene Therapies, Inc. Stock?
The 52-week high for Taysha Gene Therapies, Inc. Stock is $7.30 and the 52-week low is $2.53.

What is the market capitalization of Taysha Gene Therapies, Inc. Stock?
As of the Jul 27, 2026, the market capitalization of Taysha Gene Therapies, Inc. is 1.8B.

When is the next earnings date for Taysha Gene Therapies, Inc.?
The upcoming earnings date for Taysha Gene Therapies, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT TAYSHA GENE THERAPIES, INC.
Taysha Gene Therapies
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of ...
GOLDEN STAR
Ticker Change Signal Date
TSCO
$30.32
4.88% Jul 23
IMMR
$6.60
17.20% Jul 23
S
SW
$43.71
14.60% Jul 23
KMT
$34.39
2.70% Jul 21
DHT
$17.31
5.66% Jul 13

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE